Auris Medical Provides Update on Ongoing Clinical Trials with Intranasal Betahistine
Last subject had last treatment visit in Phase 1b trial with AM-201 in prevention of antipsychotic-induced weight gain and somnolence; […]
Last subject had last treatment visit in Phase 1b trial with AM-201 in prevention of antipsychotic-induced weight gain and somnolence; […]
DEVON, Pa., March 05, 2020 (GLOBE NEWSWIRE) — Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), the leader in innovative pharmaceutically-produced transdermal cannabinoid therapies […]
NEWARK, N.Y., March 05, 2020 (GLOBE NEWSWIRE) — IEC Electronics Corp. (NASDAQ: IEC) today announced that it has been awarded […]
TORONTO, March 05, 2020 (GLOBE NEWSWIRE) — Unisync Corp. (“Unisync”)(TSX:”UNI”) is pleased to announce that it will be featured in […]
CALGARY, Alberta, March 05, 2020 (GLOBE NEWSWIRE) — ARROW Exploration Corp. (“Arrow” or the “Company”) (TSXV: AXL) received an originating […]
CALGARY, Alberta, March 05, 2020 (GLOBE NEWSWIRE) — Shaw Communications Inc. (“Shaw”) is pleased to confirm today the substantial completion […]
NEW YORK, March 05, 2020 (GLOBE NEWSWIRE) — via NetworkWire — Champignon Brands Inc. (CSE:SHRM) today announces its placement in an […]
Nes-Ziona, Israel, March 05, 2020 (GLOBE NEWSWIRE) — Enlivex Therapeutics Ltd. (Nasdaq: ENLV), a clinical-stage immunotherapy company, today announced the closing […]
Atlanta, March 05, 2020 (GLOBE NEWSWIRE) — Acuity Brands, Inc. (NYSE: AYI) will host a conference call on Thursday, April […]
– Management to host conference call and webcast on Thursday, March 12 at 8:30 a.m. ET –Norwood, MA, March 05, […]